PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 33 filers reported holding PDL BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $101,000 | +2.0% | 32,038 | -6.0% | 0.00% | -100.0% |
| Q2 2020 | $99,000 | +57.1% | 34,072 | +52.7% | 0.00% | – |
| Q1 2020 | $63,000 | -51.5% | 22,307 | -44.2% | 0.00% | -100.0% |
| Q4 2019 | $130,000 | +38.3% | 39,965 | -8.6% | 0.00% | 0.0% |
| Q3 2019 | $94,000 | -40.1% | 43,749 | -12.6% | 0.00% | 0.0% |
| Q2 2019 | $157,000 | -35.1% | 50,043 | -23.2% | 0.00% | 0.0% |
| Q1 2019 | $242,000 | +29.4% | 65,177 | +0.9% | 0.00% | 0.0% |
| Q4 2018 | $187,000 | -7.4% | 64,580 | -15.9% | 0.00% | 0.0% |
| Q3 2018 | $202,000 | +4.1% | 76,832 | -7.3% | 0.00% | 0.0% |
| Q2 2018 | $194,000 | -27.3% | 82,869 | -8.8% | 0.00% | -50.0% |
| Q1 2018 | $267,000 | -8.9% | 90,848 | -14.9% | 0.00% | 0.0% |
| Q4 2017 | $293,000 | -12.5% | 106,779 | +8.0% | 0.00% | -33.3% |
| Q3 2017 | $335,000 | +38.4% | 98,858 | +1.0% | 0.00% | +50.0% |
| Q2 2017 | $242,000 | -2.8% | 97,908 | -10.6% | 0.00% | -33.3% |
| Q1 2017 | $249,000 | -14.4% | 109,517 | -20.2% | 0.00% | 0.0% |
| Q4 2016 | $291,000 | -28.9% | 137,310 | +12.4% | 0.00% | -50.0% |
| Q3 2016 | $409,000 | -9.9% | 122,120 | -15.6% | 0.01% | 0.0% |
| Q2 2016 | $454,000 | -4.4% | 144,626 | +1.4% | 0.01% | -14.3% |
| Q1 2016 | $475,000 | -13.6% | 142,661 | -8.2% | 0.01% | 0.0% |
| Q4 2015 | $550,000 | -22.4% | 155,432 | +10.3% | 0.01% | -30.0% |
| Q3 2015 | $709,000 | -31.4% | 140,874 | -12.4% | 0.01% | -28.6% |
| Q2 2015 | $1,034,000 | -13.8% | 160,764 | -5.8% | 0.01% | 0.0% |
| Q1 2015 | $1,200,000 | +4.3% | 170,605 | +14.4% | 0.01% | +7.7% |
| Q4 2014 | $1,150,000 | +1.5% | 149,109 | -1.7% | 0.01% | -13.3% |
| Q3 2014 | $1,133,000 | -35.7% | 151,690 | -16.6% | 0.02% | -34.8% |
| Q2 2014 | $1,761,000 | -16.6% | 181,953 | -28.4% | 0.02% | -11.5% |
| Q1 2014 | $2,111,000 | +227.8% | 254,010 | +232.7% | 0.03% | +160.0% |
| Q4 2013 | $644,000 | -42.8% | 76,341 | -46.0% | 0.01% | -63.0% |
| Q3 2013 | $1,126,000 | +20.6% | 141,289 | +16.8% | 0.03% | +50.0% |
| Q2 2013 | $934,000 | – | 120,966 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Silver Point Capital L.P. | 23,783,273 | $58,745,000 | 6.82% |
| Park West Asset Management LLC | 14,397,212 | $35,561,000 | 0.74% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 633,700 | $1,565,000 | 0.24% |
| JBF Capital, Inc. | 543,990 | $1,344,000 | 0.22% |
| Context Capital Management, LLC | 465,172 | $1,149,000 | 0.16% |
| Bellecapital International Ltd. | 108,025 | $267,000 | 0.09% |
| FNY Investment Advisers, LLC | 100,000 | $247,000 | 0.07% |
| WINTON GROUP Ltd | 291,360 | $720,000 | 0.05% |
| Freedom Investment Management, Inc. | 54,735 | $135,000 | 0.02% |
| HANCOCK WHITNEY CORP | 187,757 | $464,000 | 0.02% |